Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! 

China Clinical Trials 2017

Analysis of IND and NDA applications and approvals in China 2011-2017

Download free report on life science investment in China

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Exclusive Interview with Jonathan Wang of OrbiMed Asia: China's Market is a "Once-in-a-Lifetime Opportunity"
Week in Review: Mevion Medical of Boston Closes $150 Million Financing from China Investors
Week in Review: Hua Medicine Approved for $200 Million Hong Kong IPO
Week in Review: Alibaba Transfers Assets to Ali Health in $1.4 Billion Deal
Week in Review: Grail, an Oncology Diagnostics Company, Taps China Investors for $300 Million
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China